Viewing Study NCT05697003


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2025-12-30 @ 4:40 PM
Study NCT ID: NCT05697003
Status: UNKNOWN
Last Update Posted: 2023-03-09
First Post: 2023-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module